The EMA concluded that Melatomed’s benefits outweigh its risks and supported granting marketing authorizations in Germany, Austria, Denmark, and Sweden.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/eu-clears-generic-sleep-aid-seniors-insomnia-2025a1000z5j?src=rss
Author :
Publish date : 2025-12-15 15:28:00
Copyright for syndicated content belongs to the linked Source.